FRANK YOUNG

Allopathic & Osteopathic Physicians|Internal Medicine MACON, GA NPI 1861464091

General Payments — all program years on this page

$2,538.20

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 153
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $352.09 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $352.0922

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $492.9629
2019 $377.3424
2020 $279.8116
2021 $289.6419
2022 $269.9816
2023 $476.3827
2024 $352.0922

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087383178 Novartis Pharmaceuticals Corporation $15.09 01/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096568980 Novo Nordisk Inc $15.61 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096592440 Novo Nordisk Inc $15.58 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096657935 Novo Nordisk Inc $18.23 02/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096871659 Novo Nordisk Inc $21.48 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096960793 Novo Nordisk Inc $15.15 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097106945 Novo Nordisk Inc $21.93 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097154868 Novo Nordisk Inc $14.01 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101396570 E.R. Squibb & Sons, L.L.C. $15.40 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106380636 ABBVIE INC. $16.94 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116317238 GlaxoSmithKline, LLC. $16.26 02/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116421401 GlaxoSmithKline, LLC. $13.72 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117421010 Amgen Inc. $14.29 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117421012 Amgen Inc. $15.55 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117421014 Amgen Inc. $13.24 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125307917 Abbott Laboratories $15.91 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134981030 Lilly USA, LLC $17.60 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134991924 Lilly USA, LLC $13.07 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134997284 Lilly USA, LLC $17.03 04/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1134997286 Lilly USA, LLC $17.91 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148019428 Bausch Health US, LLC $14.81 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153300622 Dexcom, Inc. $13.28 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.